Apellis Pharmaceuticals, Inc. · NASDAQ:APLS
Rtw Investments, LP's stake in Apellis Pharmaceuticals, Inc. fell to 2.90% (Schedule 13G/A)
Event Mar 31, 2026 · Filed May 15, 2026
Rtw Investments, LP's stake in Apellis Pharmaceuticals, Inc. fell to 2.90%, 3,685,045 shares, as a passive investor on Mar 31, 2026. Filed May 15, 2026 (Schedule 13G/A).
- Stake
- 2.90%
- Shares
- 3,685,045
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| RTW Investments, LP | 2.90% | 3,685,045 |
| Roderick Wong | 2.90% | 3,685,045 |
Source
Related
- Apellis Pharmaceuticals, Inc.
- Rtw Investments, LP
- Apellis Pharmaceuticals, Inc. shareholders
- Schedule 13G · Rtw Investments, LP · Feb 17, 2026
- Schedule 13G/A · Morgan Stanley · Jun 5, 2026
- Schedule 13G/A · Deep Track Capital, LP · May 15, 2026
- Form 4 · Dunlop A. Sinclair · May 14, 2026
- Form 4 · Chopas James George · May 14, 2026
- Form 4 · Dolsten Mikael · May 14, 2026